Scott S. Wheeler - 22 Sep 2021 Form 3 Insider Report for Thorne Healthtech, Inc.

Role
Chief Financial Officer
Signature
/s/ Scott Wheeler
Issuer symbol
N/A
Transactions as of
22 Sep 2021
Net transactions value
$0
Form type
3
Filing time
22 Sep 2021, 18:11:07 UTC
Next filing
28 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding THRN Class B Common Stock 33,820 22 Sep 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 19,580 $1.16 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 1,335 $1.16 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 2,670 $1.16 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 3,115 $1.16 Direct F3, F4
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 64,080 $1.35 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 44,500 $4.49 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 44,500 $6.74 Direct F2, F3
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class A Common Stock 478,820 $5.12 Direct F3, F5
holding THRN Employee Stock Option (Right to buy) 22 Sep 2021 Class B Common Stock 1,335 $14.46 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Class B Common Stock shall be converted into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock (the "IPO").
F2 All of the shares subject to the option are fully vested and exercisable as of the date hereof.
F3 Immediately prior to the completion of the IPO, the Class A Common Stock shall be re-named Common Stock.
F4 100% of the shares subject to the option vest upon exercise in full of a warrant held by Diversified Natural Products, Inc., subject to the Reporting Person continuing as a service provider through such date of exercise.
F5 One-fourth of the shares subject to the option vested on October 10, 2019 and one-fourth of the shares subject to the option vest on each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.